If you have ever heard of PrEP before, you know it is marketed as a once-daily pill that prevents HIV. Although PrEP has been revolutionary in helping to End the Epidemic, it disregards patients who are uncomfortable with handling a daily pill regimen-or the more common reason which is forgetting to take a pill every day. In December 2021, APRETUDE, the first and only long-acting injectable version of PrEP was introduced by VIIV healthcare. It involves an optional oral lead-in for 28 days, followed by an injection in the gluteal muscle at the end of the oral lead-in. After that, injections are given every two months with a negative HIV antigen and viral load test needed the week before.

Seems pretty great right? It can definitely be an option to look into if you’re turned off by pills. What’s also great is the fact that VIIV included cisgender men, cisgender women, and transgender women in their clinical studies. The results showed that HIV transmissions occurred less often with Apretude compared to Truvada-which is one of the pill versions of PrEP. The challenge now is a matter of getting it covered through your insurance. Thankfully prep navigators are here to spare you the headache from dealing with insurance and can figure out if Apretude is covered on your plan. We’ll also schedule your visits and ensure your concerns and needs are addressed. Call a PrEP navigator today to talk more.

Learn more at: https://apretude.com/